Australia markets closed

    +33.90 (+0.43%)
  • ASX 200

    +32.40 (+0.43%)

    +0.0002 (+0.03%)
  • OIL

    -2.04 (-2.60%)
  • GOLD

    +15.10 (+0.74%)
  • Bitcoin AUD

    +1,065.52 (+1.37%)
  • CMC Crypto 200

    0.00 (0.00%)

    +0.0003 (+0.05%)

    -0.0002 (-0.02%)
  • NZX 50

    +29.57 (+0.25%)

    -67.09 (-0.37%)
  • FTSE

    +21.79 (+0.28%)
  • Dow Jones

    +62.42 (+0.16%)
  • DAX

    +48.88 (+0.28%)
  • Hang Seng

    -17.09 (-0.10%)
  • NIKKEI 225

    +836.48 (+2.19%)

The Zacks Analyst Blog Highlights Apple, Meta Platforms, Mastercard, CVS Health and Ameriprise Financial

For Immediate Release

Chicago, IL – February 1, 2023 – announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Apple Inc. AAPL, Meta Platforms, Inc. META, Mastercard Inc. MA, CVS Health Corp. CVS and Ameriprise Financial, Inc. AMP.

Here are highlights from Tuesday’s Analyst Blog:

Q4 Earnings Season Scorecard and Analyst Reports for Apple, Meta and MasterCard

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features a real-time update on the ongoing Q4 earnings season and new research reports on 16 major stocks, including Apple Inc. (AAPL), Meta Platforms, Inc. (META) and Mastercard Inc. (MA). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.

You can see all of today’s research reports here >>>

Q4 Earnings Season Scorecard

Including all the reports that came out before the market's open this morning (January 31st), we now have Q4 results from 167 S&P 500 members or 33.4% of the index's total membership.

Total earnings for these companies are up +2.1% from the same period last year on +7.5% higher revenues, with 73.1% beating EPS estimates and 68.9% beating revenue estimates.

The growth pace for these 167 index members, for earnings as well as revenues, is in-line with the expected decelerating trend. That said, there is a divergence between the Q4 EPS and revenue beats percentages, with revenue beats about in-line with historical trends but EPS beats on the low side.

Looking at Q4 as a whole, combining the actual results that have come out with estimates for the still-to-come companies, S&P 500 earnings are on track to be down -6.3% from the same period last year on +4.7% higher revenues.

For the current period (2023 Q1), S&P 500 earnings are currently expected to be down -6.2% on +2.3% higher revenues. Estimates for the period have been coming down, with the current -6.2% expected decline down from -4% on January 6th and -2.9% in mid-December 2022.

This could change as we go through the remainder of this reporting cycle. But at this stage in the Q4 earnings season, the magnitude of negative revisions isn't of the level that many in the market appeared to fear a few weeks back. It is primarily in this context that the Q4 earnings season has proven, at this stage at least, to be better than feared.

Today's Featured Analyst Reports

Shares of Apple have held up better than the broader Tech sector over the past year (-18% vs. -23.9% for the Zacks Tech sector), but have lagged the broader market (-18% vs. -13% for the S&P 500 index). The company’s holiday season iPhone shipments are expected to suffer from disruptions at its Chinese partner Foxconn’s factory in Zhengzhou. The Zacks analyst expects Apple to ship roughly 70 million iPhones in the first quarter of fiscal 2023.

The company expects year-over-year revenue growth to decelerate in the fiscal first quarter compared with the fiscal fourth quarter due to unfavorable forex. Mac revenues are expected to be negatively impacted by forex. Apple expects Mac revenues to decline substantially year over year during the December quarter.

Services revenue growth is expected to be negatively impacted by challenging macroeconomic conditions, unfavorable forex, as well as weakness in digital advertising and gaming. Nevertheless, a growing subscriber base in the Services business and a strong liquidity position are key catalysts.

(You can read the full research report on Apple here >>>)

Shares of Meta Platforms have underperformed the Zacks Internet - Software industry over the past year (-53.9% vs. -48.0%). The company is suffering from challenging macroeconomic conditions that is negatively impacting its advertising spending. Unfavorable forex, targeting and measurement headwinds due to Apple’s iOS changes, normalization of e-commerce after the pandemic peak and higher inflation hurt growth in the reported quarter.

User base in Europe declined in the reported quarter. Meta’s fourth-quarter guidance reflects macroeconomic and forex concerns. Weak advertising demand is a headwind. Meta expects Reels to monetize much slower than feed or stories. Shares have underperformed the industry in the past year.

However, Meta is benefiting from steady user growth across all regions, particularly Asia Pacific. Increased engagement for its products like Instagram, WhatsApp, Messenger and Facebook has been a major growth driver.

(You can read the full research report on Meta Platforms here >>>)

Shares of Mastercard have declined -5.3% over the past year against the Zacks Financial Transaction Services industry’s decline of  -10.8%. The company’s steep operating expenses might stress margins. High rebates and incentives may weigh on net revenues. Its dividend yield is still lower than the industry average. As such, the stock warrants a cautious stance.

However, Numerous acquisitions are helping the company to grow addressable markets and drive new revenue streams. The COVID-19 crisis accelerated the adoption of digital and contactless solutions, providing an opportunity for MA's business to expedite its shift to the digital mode.

The company’s growing footprint in the crypto universe can position it for long-term growth. It is well-poised to gain from steady cash-generating abilities. A strong capital position allows MA to pursue acquisitions and deploy capital.

(You can read the full research report on Mastercard here >>>)

Other noteworthy reports we are featuring today include CVS Health Corp. and Ameriprise Financial, Inc.

Why Haven’t You Looked at Zacks' Top Stocks?

Since 2000, our top stock-picking strategies have blown away the S&P's +6.2 average gain per year. Amazingly, they soared with average gains of +46.4%, +49.5% and +55.2% per year. Today you can access their live picks without cost or obligation.

See Stocks Free >>

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit for information about the performance numbers displayed in this press release.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Apple Inc. (AAPL) : Free Stock Analysis Report

Mastercard Incorporated (MA) : Free Stock Analysis Report

Ameriprise Financial, Inc. (AMP) : Free Stock Analysis Report

CVS Health Corporation (CVS) : Free Stock Analysis Report

Meta Platforms, Inc. (META) : Free Stock Analysis Report

To read this article on click here.

Zacks Investment Research